The Board of Investments (BOI) has approved the registration of Asian Hospital Inc.’s P334-million CyberKnife Radiotherapy Service—the first AI-driven cancer treatment technology to be made available in the country.
In a statement issued Monday, the BOI said the system offers non-invasive, robotic radiosurgery that delivers sub-millimeter precision radiation, drastically reducing exposure to healthy tissues. This innovation shortens treatment duration from the typical 28 to 39 sessions to just one to five sessions, the agency added.
The system is approved by the U.S. Food and Drug Administration.
According to the BOI, the CyberKnife unit will operate as a stand-alone facility within the Asian Cancer Institute, featuring its own entrance, consultation and CT rooms, and a radiation-safe bunker.
The project is part of the medical network of Metro Pacific Health Corp., which manages 27 hospitals and six cancer care centers nationwide, the BOI noted.
AHI is partnering with the Philippine Children’s Medical Center to serve pediatric cancer patients under PhilHealth’s “No Balance Billing” Program. Additional support from HMOs, the Department of Health’s Medical Assistance for Indigent Patients (MAIP) program, and the Department of Social Welfare and Development’s medical aid ensures that even low-income patients can benefit from this advanced technology, the BOI said.
